{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T13:42:23Z","timestamp":1792762943614,"version":"4.5.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2018,7,16]],"date-time":"2018-07-16T00:00:00Z","timestamp":1531699200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Med"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1038\/s41591-018-0106-7","type":"journal-article","created":{"date-parts":[[2018,7,16]],"date-time":"2018-07-16T08:19:40Z","timestamp":1531729180000},"page":"1317-1323","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":162,"title":["Fetal gene therapy for neurodegenerative disease of infants"],"prefix":"10.1038","volume":"24","author":[{"given":"Giulia","family":"Massaro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Citra N. Z.","family":"Mattar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew M. S.","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ernestas","family":"Sirka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzanne M. K.","family":"Buckley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bronwen R.","family":"Herbert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Karlsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dany P.","family":"Perocheau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Derek","family":"Burke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Heales","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Richard-Londt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9821-0342","authenticated-orcid":false,"given":"Sebastian","family":"Brandner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mylene","family":"Huebecker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Priestman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frances M.","family":"Platt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Mills","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arijit","family":"Biswas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan D.","family":"Cooper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerry K. Y.","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seng H.","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4970-4730","authenticated-orcid":false,"given":"Simon N.","family":"Waddington","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahad A.","family":"Rahim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,7,16]]},"reference":[{"key":"106_CR1","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.bcmd.2010.08.012","volume":"46","author":"N Gupta","year":"2011","unstructured":"Gupta, N., Oppenheim, I. M., Kauvar, E. F., Tayebi, N. & Sidransky, E. Type 2 Gaucher disease: phenotypic variation and genotypic heterogeneity. Blood Cells Mol. Dis. 46, 75\u201384 (2011).","journal-title":"Blood Cells Mol. Dis."},{"key":"106_CR2","doi-asserted-by":"publisher","first-page":"17483","DOI":"10.1073\/pnas.0708086104","volume":"104","author":"IB Enquist","year":"2007","unstructured":"Enquist, I. B. et al. Murine models of acute neuronopathic Gaucher disease. Proc. Natl Acad. Sci. USA 104, 17483\u201317488 (2007).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"106_CR3","doi-asserted-by":"crossref","unstructured":"Farfel-Becker, T. et al. Spatial and temporal correlation between neuron loss and neuroinflammation in a mouse model of neuronopathic Gaucher disease. Hum. Mol. Genet. (2011).","DOI":"10.1093\/hmg\/ddr019"},{"key":"106_CR4","doi-asserted-by":"crossref","unstructured":"Farfel-Becker, T. et al. Neuronal accumulation of glucosylceramide in a mouse model of neuronopathic Gaucher disease leads to neurodegeneration. Hum. Mol. Genet. (2013).","DOI":"10.1093\/hmg\/ddt468"},{"key":"106_CR5","doi-asserted-by":"publisher","first-page":"e43310","DOI":"10.1371\/journal.pone.0043310","volume":"7","author":"MA Cabrera-Salazar","year":"2012","unstructured":"Cabrera-Salazar, M. A. et al. Systemic delivery of a glucosylceramide synthase inhibitor reduces CNS substrates and increases lifespan in a mouse model of type 2 Gaucher disease. PLoS ONE 7, e43310 (2012).","journal-title":"PLoS ONE"},{"key":"106_CR6","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1038\/gt.2011.157","volume":"19","author":"AA Rahim","year":"2012","unstructured":"Rahim, A. A. et al. In utero administration of Ad5 and AAV pseudotypes to the fetal brain leads to efficient, widespread and long-term gene expression. Gene Ther. 19, 936\u2013946 (2012).","journal-title":"Gene Ther."},{"key":"106_CR7","doi-asserted-by":"publisher","first-page":"e101","DOI":"10.1038\/mtna.2013.27","volume":"2","author":"MR Haddad","year":"2013","unstructured":"Haddad, M. R., Donsante, A., Zerfas, P. & Kaler, S. G. Fetal brain-directed AAV gene therapy results in rapid, robust, and persistent transduction of mouse choroid plexus epithelia. Mol. Ther. Nucleic Acids 2, e101 (2013).","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"106_CR8","doi-asserted-by":"publisher","first-page":"12382","DOI":"10.1128\/JVI.75.24.12382-12392.2001","volume":"75","author":"MA Passini","year":"2001","unstructured":"Passini, M. A. & Wolfe, J. H. Widespread gene delivery and structure-specific patterns of expression in the brain after intraventricular injections of neonatal mice with an adeno-associated virus vector. J. Virol. 75, 12382\u201312392 (2001).","journal-title":"J. Virol."},{"key":"106_CR9","doi-asserted-by":"crossref","unstructured":"Sardi, S. P. et al. CNS expression of glucocerebrosidase corrects \u03b1-synuclein pathology and memory in a mouse model of Gaucher-related synucleinopathy. Proc. Natl Acad. Sci. USA (2011).","DOI":"10.1073\/pnas.1108197108"},{"key":"106_CR10","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1002\/(SICI)1096-9896(199908)188:4<407::AID-PATH377>3.0.CO;2-Z","volume":"188","author":"KP Zimmer","year":"1999","unstructured":"Zimmer, K. P. et al. Intracellular transport of acid \u03b2-glucosidase and lysosome-associated membrane proteins is affected in Gaucher\u2019s disease (G202R mutation). J. Pathol. 188, 407\u2013414 (1999).","journal-title":"J. Pathol."},{"key":"106_CR11","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1038\/nbt.1515","volume":"27","author":"KD Foust","year":"2009","unstructured":"Foust, K. D. et al. Intravascular AAV9 preferentially targets neonatal neurons and adult astrocytes. Nat. Biotechnol. 27, 59\u201365 (2009).","journal-title":"Nat. Biotechnol."},{"key":"106_CR12","doi-asserted-by":"publisher","first-page":"3505","DOI":"10.1096\/fj.11-182311","volume":"25","author":"AA Rahim","year":"2011","unstructured":"Rahim, A. A. et al. Intravenous administration of AAV2\/9 to the fetal and neonatal mouse leads to differential targeting of CNS cell types and extensive transduction of the nervous system. FASEB J. 25, 3505\u20133518 (2011).","journal-title":"FASEB J."},{"key":"106_CR13","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/gt.2011.216","volume":"20","author":"CN Mattar","year":"2013","unstructured":"Mattar, C. N. et al. Systemic delivery of scAAV9 in fetal macaques facilitates neuronal transduction of the central and peripheral nervous systems. Gene Ther. 20, 69\u201383 (2013).","journal-title":"Gene Ther."},{"key":"106_CR14","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1089\/humc.2017.010","volume":"28","author":"Y Sehara","year":"2017","unstructured":"Sehara, Y. et al. Persistent expression of dopamine-synthesizing enzymes 15 years after gene transfer in a primate model of Parkinson\u2019s disease. Hum. Gene Ther. Clin. Dev. 28, 74\u201379 (2017).","journal-title":"Hum. Gene Ther. Clin. Dev."},{"key":"106_CR15","doi-asserted-by":"publisher","first-page":"1994","DOI":"10.1056\/NEJMoa1407309","volume":"371","author":"AC Nathwani","year":"2014","unstructured":"Nathwani, A. C. et al. Long-term safety and efficacy of factor IX gene therapy in hemophilia B. N. Engl. J. Med. 371, 1994\u20132004 (2014).","journal-title":"N. Engl. J. Med."},{"key":"106_CR16","doi-asserted-by":"crossref","unstructured":"McCain, L. & Flake, A. W. In utero stem cell transplantation and gene therapy\u2014recent progress and the potential for clinical application. Best Pract. Res Clin Obstet. Gynaecol. (2015).","DOI":"10.1016\/j.bpobgyn.2015.08.006"},{"key":"106_CR17","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1056\/NEJMoa1706198","volume":"377","author":"JR Mendell","year":"2017","unstructured":"Mendell, J. R. et al. Single-dose gene-replacement therapy for spinal muscular atrophy. N. Engl. J. Med. 377, 1713\u20131722 (2017).","journal-title":"N. Engl. J. Med."},{"key":"106_CR18","unstructured":"Tardieu, M. et al. Intracerebral administration of AAV rh.10 carrying human SGSH and SUMF1 cDNAs in children with MPSIIIA disease: results of a phase I\/II trial. Hum. Gene Ther (2014)."},{"key":"106_CR19","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1016\/0026-0495(89)90165-0","volume":"38","author":"DJ Barton","year":"1989","unstructured":"Barton, D. J., Ludman, M. D., Benkov, K., Grabowski, G. A. & LeLeiko, N. S. Resting energy expenditure in Gaucher\u2019s disease type 1: effect of Gaucher\u2019s cell burden on energy requirements. Metabolism 38, 1238\u20131243 (1989).","journal-title":"Metabolism"},{"key":"106_CR20","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1038\/gt.2010.105","volume":"18","author":"KMR Prasad","year":"2011","unstructured":"Prasad, K. M. R., Xu, Y., Yang, Z., Acton, S. T. & French, B. A. Robust cardiomyocyte-specific gene expression following systemic injection of AAV: in vivo gene delivery follows a Poisson distribution. Gene Ther. 18, 43\u201352 (2011).","journal-title":"Gene Ther."},{"key":"106_CR21","doi-asserted-by":"publisher","first-page":"3757","DOI":"10.1172\/JCI79322","volume":"125","author":"DA Zeevi","year":"2015","unstructured":"Zeevi, D. A. et al. Proof-of-principle rapid noninvasive prenatal diagnosis of autosomal recessive founder mutations. J. Clin. Investig. 125, 3757\u20133765 (2015).","journal-title":"J. Clin. Investig."},{"key":"106_CR22","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1002\/pd.4663","volume":"35","author":"J Verma","year":"2015","unstructured":"Verma, J. et al. Inherited metabolic disorders: prenatal diagnosis of lysosomal storage disorders. Prenat. Diagn. 35, 1137\u20131147 (2015).","journal-title":"Prenat. Diagn."},{"key":"106_CR23","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1053\/j.sempedsurg.2012.10.010","volume":"22","author":"EG Pearson","year":"2013","unstructured":"Pearson, E. G. & Flake, A. W. Stem cell and genetic therapies for the fetus. Semin. Pediatr. Surg. 22, 56\u201361 (2013).","journal-title":"Semin. Pediatr. Surg."},{"key":"106_CR24","doi-asserted-by":"publisher","first-page":"397879","DOI":"10.1155\/2015\/397879","volume":"2015","author":"MS Nivsarkar","year":"2015","unstructured":"Nivsarkar, M. S. et al. Evidence for contribution of CD4+\u2009 CD25+\u2009regulatory T cells in maintaining immune tolerance to human factor IX following perinatal adenovirus vector delivery. J. Immunol. Res. 2015, 397879 (2015).","journal-title":"J. Immunol. Res."},{"key":"106_CR25","doi-asserted-by":"crossref","unstructured":"Tai, D. S. et al. Development of operational immunologic tolerance with neonatal gene transfer in nonhuman primates: preliminary studies. Gene Ther. (2015).","DOI":"10.1038\/gt.2015.65"},{"key":"106_CR26","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1182\/blood-2002-03-0779","volume":"101","author":"SN Waddington","year":"2003","unstructured":"Waddington, S. N. et al. In utero gene transfer of human factor IX to fetal mice can induce postnatal tolerance of the exogenous clotting factor. Blood 101, 1359\u20131366 (2003).","journal-title":"Blood"},{"key":"106_CR27","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1038\/mt.2011.72","volume":"19","author":"SJ Gray","year":"2011","unstructured":"Gray, S. J. et al. Preclinical differences of intravascular AAV9 delivery to neurons and glia: a comparative study of adult mice and nonhuman primates. Mol. Ther. 19, 1058\u20131069 (2011).","journal-title":"Mol. Ther."},{"key":"106_CR28","unstructured":"U.S. National Institutes of Health, and Recombinant DNA Advisory Committee. Prenatal gene tranfer: scientific, medical, and ethical issues: a report of the Recombinant DNA Advisory Committee. Hum. Gene Ther. 11, 1211\u20131229 (2000)."},{"key":"106_CR29","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1016\/j.nbd.2011.12.027","volume":"45","author":"SN Pressey","year":"2012","unstructured":"Pressey, S. N., Smith, D. A., Wong, A. M., Platt, F. M. & Cooper, J. D. Early glial activation, synaptic changes and axonal pathology in the thalamocortical system of Niemann-Pick type C1 mice. Neurobiol. Dis. 45, 1086\u20131100 (2012).","journal-title":"Neurobiol. Dis."},{"key":"106_CR30","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1046\/j.1365-2818.1999.00457.x","volume":"193","author":"HJ Gundersen","year":"1999","unstructured":"Gundersen, H. J., Jensen, E. B., Kieu, K. & Nielsen, J. The efficiency of systematic sampling in stereology\u2014reconsidered. J. Microsc. 193, 199\u2013211 (1999).","journal-title":"J. Microsc."},{"key":"106_CR31","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1111\/j.1365-2818.1986.tb04282.x","volume":"142","author":"AJ Baddeley","year":"1986","unstructured":"Baddeley, A. J., Gundersen, H. J. & Cruz-Orive, L. M. Estimation of surface area from vertical sections. J. Microsc. 142, 259\u2013276 (1986).","journal-title":"J. Microsc."},{"key":"106_CR32","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1002\/rcm.1977","volume":"19","author":"K Mills","year":"2005","unstructured":"Mills, K., Eaton, S., Ledger, V., Young, E. & Winchester, B. The synthesis of internal standards for the quantitative determination of sphingolipids by tandem mass spectrometry. Rapid Commun. Mass Spectrometry 19, 1739\u20131748 (2005).","journal-title":"Rapid Commun. Mass Spectrometry"},{"key":"106_CR33","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.cca.2014.08.002","volume":"438","author":"C Auray-Blais","year":"2015","unstructured":"Auray-Blais, C. et al. Urinary biomarker investigation in children with Fabry disease using tandem mass spectrometry. Clin. Chim. Acta 438, 195\u2013204 (2015).","journal-title":"Clin. Chim. Acta"},{"key":"106_CR34","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.ab.2004.03.051","volume":"331","author":"DC Neville","year":"2004","unstructured":"Neville, D. C. et al. Analysis of fluorescently labeled glycosphingolipid-derived oligosaccharides following ceramide glycanase digestion and anthranilic acid labeling. Anal. Biochem. 331, 275\u2013282 (2004).","journal-title":"Anal. Biochem."},{"key":"106_CR35","doi-asserted-by":"publisher","first-page":"72ra18","DOI":"10.1126\/scitranslmed.3001777","volume":"3","author":"MA Passini","year":"2011","unstructured":"Passini, M. A. et al. Antisense oligonucleotides delivered to the mouse CNS ameliorate symptoms of severe spinal muscular atrophy. Sci. Transl. Med. 3, 72ra18 (2011).","journal-title":"Sci. Transl. Med."},{"key":"106_CR36","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1038\/gt.2009.157","volume":"17","author":"E Ayuso","year":"2010","unstructured":"Ayuso, E. et al. High AAV vector purity results in serotype- and tissue-independent enhancement of transduction efficiency. Gene Ther. 17, 503\u2013510 (2010).","journal-title":"Gene Ther."},{"key":"106_CR37","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1038\/gt.2008.186","volume":"16","author":"AA Rahim","year":"2009","unstructured":"Rahim, A. A. et al. Efficient gene delivery to the adult and fetal CNS using pseudotyped non-integrating lentiviral vectors. Gene Ther. 16, 509\u2013520 (2009).","journal-title":"Gene Ther."},{"key":"106_CR38","doi-asserted-by":"crossref","unstructured":"Kim, J. Y., Grunke, S. D., Levites, Y., Golde, T. E. & Jankowsky, J. L. Intracerebroventricular viral injection of the neonatal mouse brain for persistent and widespread neuronal transduction. J. Vis. Exp. (2014).","DOI":"10.3791\/51863"},{"key":"106_CR39","doi-asserted-by":"publisher","first-page":"1950","DOI":"10.1038\/mt.2011.107","volume":"19","author":"CNZ Mattar","year":"2011","unstructured":"Mattar, C. N. Z. et al. Stable human FIX expression after 0.9G intrauterine gene transfer of self-complementary adeno-associated viral vector 5 and 8 in macaques. Mol. Ther. 19, 1950\u20131960 (2011).","journal-title":"Mol. Ther."},{"key":"106_CR40","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/978-1-61779-873-3_12","volume":"891","author":"CN Mattar","year":"2012","unstructured":"Mattar, C. N., Biswas, A., Choolani, M. & Chan, J. K. Animal models for prenatal gene therapy: the nonhuman primate model. Methods Mol. Biol. 891, 249\u2013271 (2012).","journal-title":"Methods Mol. Biol."},{"key":"106_CR41","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.bbr.2004.06.019","volume":"157","author":"A Lubics","year":"2005","unstructured":"Lubics, A. et al. Neurological reflexes and early motor behavior in rats subjected to neonatal hypoxic\u2013ischemic injury. Behav. Brain Res. 157, 157\u2013165 (2005).","journal-title":"Behav. Brain Res."},{"key":"106_CR42","doi-asserted-by":"publisher","first-page":"8.12.1","DOI":"10.1002\/0471142301.ns0812s15","volume":"15","author":"RJ Carter","year":"2001","unstructured":"Carter, R. J., Morton, J. & Dunnett, S. B. Motor coordination and balance in rodents. Curr. Protoc. Neurosci. 15, 8.12.1\u20138.12.14 (2001).","journal-title":"Curr. Protoc. Neurosci."},{"key":"106_CR43","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1111\/j.1399-0004.1978.tb04242.x","volume":"13","author":"DA Wenger","year":"1978","unstructured":"Wenger, D. A., Clark, C., Sattler, M. & Wharton, C. Synthetic substrate \u03b2-glucosidase activity in leukocytes: a reproducible method for the identification of patients and carriers of Gaucher\u2019s disease. Clin. Genet. 13, 145\u2013153 (1978).","journal-title":"Clin. Genet."}],"container-title":["Nature Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41591-018-0106-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41591-018-0106-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41591-018-0106-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,3]],"date-time":"2023-09-03T15:46:00Z","timestamp":1693755960000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41591-018-0106-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,16]]},"references-count":43,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2018,9]]}},"alternative-id":["106"],"URL":"https:\/\/doi.org\/10.1038\/s41591-018-0106-7","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.733639927.793556692","asserted-by":"object"},{"id-type":"doi","id":"10.3410\/f.733639927.793548923","asserted-by":"object"}]},"ISSN":["1078-8956","1546-170X"],"issn-type":[{"value":"1078-8956","type":"print"},{"value":"1546-170X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,7,16]]},"assertion":[{"value":"20 June 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 May 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"S.H.C. is an employee at Sanofi, a biopharmaceutical company.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}